BLOG
Review of FDA July 2022 DSCSA Draft Guidance on Identifying Trading Partners
Review of FDA July 2022 DSCSA Draft Guidance on Identifying Trading Partners Written-by: Sumeet Singh, CEO As we rocket towards the Event Horizon of the November 2023 DSCSA implementation deadline, industry and FDA are each figuring out how exactly the law will be...
Recent Articles
Five Rivers Announces VAWD Accreditation for 1st of 68 Clients
Five Rivers is proud to announce that the first of 68 companies that have retained Five Rivers for VAWD services, has been awarded VAWD...
Newest Action by State Boards per DQSA & Federal Mandates
Newest Action by State Boards per DQSA & Federal Mandates In this post, we examine how the DQSA impacts State Licensing and discuss what is in...
VAWD Program Generates *Estimated* $5.79 Million in 4 Months
VAWD Program Generates *Estimated* $5.79 Million in 4 Months This blog post focuses on the financials behind the VAWD Program. Five Rivers estimates...
New Dynamic Duo Attempt Denting Diabetic Supply Gray Market
New Dynamic Duo Attempt Denting Diabetic Supply Gray Market It seems as if OptumRX’s reimbursement policy change is here to stay. Now, with the new...
NABP’s Potential Double Standard
NABP's Potential Double Standard In this week's post, we explore how the NABP is potentially setting a double-standard as it applies its rules to...
NABP Launches VDIP Accreditation for OTC Suppliers
NABP Launches VDIP Accreditation for OTC Suppliers NABP launched VDIP Accreditation for diagnostic over-the-counter (OTC) medical devices on...
